(NASDAQ: ASMB) Assembly Biosciences's forecast annual earnings growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast earnings growth rate of 9.68%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 15.82%.
Assembly Biosciences's earnings in 2025 is -$39,918,000.On average, 1 Wall Street analyst forecast ASMB's earnings for 2025 to be -$55,448,635, with the lowest ASMB earnings forecast at -$55,448,635, and the highest ASMB earnings forecast at -$55,448,635. On average, 1 Wall Street analyst forecast ASMB's earnings for 2026 to be -$74,618,893, with the lowest ASMB earnings forecast at -$74,618,893, and the highest ASMB earnings forecast at -$74,618,893.
In 2027, ASMB is forecast to generate -$92,185,265 in earnings, with the lowest earnings forecast at -$92,185,265 and the highest earnings forecast at -$92,185,265.